EGYPTIAN PHARMACEUTICAL DIRECTORY
PENTOTITIS 100 MG 30 CAPS.(N/A YET)
OFFICIAL RETAIL PRICE
EGP 66.00
Active Molecule
PENTOSAN
Form & Route
Oral Solid (Tablets / Capsules)
Manufacturer
ANDALOUS PHARMA
Therapeutic Class
ANTI-INFLAMMATORY
Commercial brands in ANTI-INFLAMMATORY that achieve equivalent therapeutic outcomes.
ALPHA-AMYLASE
EGP 55.00
Saves EGP 11.00
TRYPSIN + CHYMOTRYPSIN + PAPIN
EGP 144.00
+EGP 78.00
OMEGA 3 + OMEGA 6 + MENTHOL + CAMPHOR + CLOVE + AVOCADO OIL + ALMOND OIL + EUCALYPTUS +
EGP 98.00
+EGP 32.00
DIACEREIN
EGP 150.00
+EGP 84.00
TRYPSIN + RUTOSIDE + BROMALIN
EGP 160.00
+EGP 94.00
BROMELAIN + RUTOSIDE + TRYPSIN
EGP 190.00
+EGP 124.00
DIACEREIN
EGP 156.00
+EGP 90.00
SEA WATER - PANTHENOL - HYALORUNIC ACID
EGP 150.00
+EGP 84.00
EGP 41.00
Saves EGP 25.00
EGP 58.00
Saves EGP 8.00
BROMELAIN + RUTOSIDE + TRYPSIN
EGP 69.00
+EGP 3.00
AESCIN
EGP 12.00
Saves EGP 54.00
TRYPSIN + BROMELAIN + RHIZOSIDE + PAPAIN + PANCREATIN
EGP 240.00
+EGP 174.00
GINGER
EGP 45.00
Saves EGP 21.00
TRYPSIN + CHYMOTRYPSIN + BROMELAIN
EGP 144.00
+EGP 78.00
RUTIN 200MG + BROMELAIN 80MG + TRYPSIN 90MG
EGP 150.00
+EGP 84.00
RUTIN + BROMELAIN + TRYPSIN + L-LEUCINE
EGP 198.00
+EGP 132.00
PENTOSAN POLYSULPHATE
EGP 58.00
Saves EGP 8.00
PENTOSAN POLYSULPHATE
EGP 46.00
Saves EGP 20.00
PENTOSAN POLYSULPHATE
EGP 7.00
Saves EGP 59.00
PENTOSAN POLYSULPHATE
EGP 6.50
Saves EGP 59.50
INDOMETHACIN
EGP 46.00
Saves EGP 20.00
ALPHA AMYLASE + CALCIUM
EGP 80.00
+EGP 14.00
TRYPSIN + BROMALINE + RUTIN
EGP 89.00
+EGP 23.00
ALPHA AMYLASE 200 CEIP UNIT/ML
EGP 57.00
Saves EGP 9.00
TRYPSIN 82MG - CHYMOTRYPSIN 14 MG-BROMELAIN 180 MG -RUTOSIDE 200 MG - L.LEUCIN 30 MG
EGP 225.00
+EGP 159.00
BROMELAIN + RUTOSIDE + TRYPSIN + L-LEUCINE
EGP 110.00
+EGP 44.00
TURMERIC + NIGELLA SATIVA + BLACK PEPPER
EGP 285.00
+EGP 219.00
ALPHA AMYLASE
EGP 185.00
+EGP 119.00
DIACEREIN
EGP 44.00
Saves EGP 22.00
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.